MLSS RSI Chart
Last 7 days
4.5%
Last 30 days
22.8%
Last 90 days
2.9%
Trailing 12 Months
-32.0%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 9.5M | 0 | 0 | 0 |
2023 | 8.7M | 10.0M | 9.8M | 9.8M |
2022 | 10.1M | 9.3M | 9.4M | 8.8M |
2021 | 6.6M | 8.8M | 9.7M | 10.3M |
2020 | 8.3M | 6.2M | 5.5M | 5.4M |
2019 | 9.7M | 9.6M | 9.8M | 8.4M |
2018 | 9.4M | 9.3M | 8.1M | 9.6M |
2017 | 10.7M | 10.8M | 10.5M | 11.3M |
2016 | 10.3M | 10.9M | 11.6M | 10.6M |
2015 | 10.5M | 9.7M | 9.7M | 9.5M |
2014 | 10.1M | 10.4M | 10.5M | 10.3M |
2013 | 9.2M | 9.2M | 9.5M | 10.0M |
2012 | 7.9M | 7.7M | 8.1M | 8.6M |
2011 | 9.4M | 9.1M | 8.7M | 8.4M |
2010 | 0 | 0 | 0 | 9.7M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Apr 23, 2024 | goldman neal i | acquired | 12,169 | 0.55 | 22,127 | - |
Apr 22, 2024 | goldman neal i | acquired | 30,275 | 0.54 | 56,065 | - |
Dec 11, 2023 | goldman neal i | acquired | 78,750 | 0.63 | 125,000 | - |
Oct 23, 2023 | trombetta giandomenico | back to issuer | -1,358 | 0.97 | -1,400 | - |
Oct 19, 2023 | trombetta giandomenico | back to issuer | -1,900 | 0.95 | -2,000 | - |
Oct 19, 2023 | trombetta giandomenico | back to issuer | -17,670 | 0.95 | -18,600 | - |
Oct 18, 2023 | trombetta giandomenico | back to issuer | -2,760 | 0.92 | -3,000 | - |
Aug 01, 2023 | milligan peter j | acquired | 49,999 | 1.08 | 46,296 | president |
Jun 28, 2023 | trombetta giandomenico | acquired | 100,000 | 0.89 | 112,360 | - |
Jun 28, 2023 | casamento benedetta i | acquired | 120,000 | 0.89 | 134,831 | - |
Which funds bought or sold MLSS recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 15, 2024 | STATE STREET CORP | unchanged | - | -7,880 | 73,380 | -% |
May 15, 2024 | CITADEL ADVISORS LLC | reduced | -17.58 | -8,572 | 24,949 | -% |
May 15, 2024 | Royal Bank of Canada | added | 1.22 | - | - | -% |
May 15, 2024 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | unchanged | - | -33,564 | 312,559 | 0.01% |
May 15, 2024 | MILLENNIUM MANAGEMENT LLC | reduced | -22.69 | -5,084 | 11,758 | -% |
May 15, 2024 | Mariner, LLC | unchanged | - | -8,145 | 75,850 | -% |
May 15, 2024 | TWO SIGMA SECURITIES, LLC | new | - | 9,798 | 9,798 | -% |
May 15, 2024 | Tower Research Capital LLC (TRC) | added | 30.46 | 1,480 | 9,798 | -% |
May 15, 2024 | TOWNSQUARE CAPITAL LLC | unchanged | - | -721 | 6,714 | -% |
May 15, 2024 | BARCLAYS PLC | unchanged | - | - | - | -% |
Unveiling Milestone Scientific Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Milestone Scientific Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
ABT | 181.0B | 40.3B | 32.18 | 4.49 | ||||
BDX | 68.3B | 19.7B | 51.24 | 3.46 | ||||
ALGN | 20.4B | 3.9B | 44.2 | 5.22 | ||||
BAX | 18.0B | 14.9B | 6.79 | 1.21 | ||||
MID-CAP | ||||||||
ATR | 9.8B | 3.5B | 31.27 | 2.76 | ||||
HSIC | 9.6B | 12.5B | 24.63 | 0.77 | ||||
BIO | 8.4B | 2.6B | -26.02 | 3.22 | ||||
XRAY | 5.9B | 3.9B | -62.84 | 1.49 | ||||
AXNX | 3.4B | 387.1M | -216.3 | 8.9 | ||||
PDCO | 2.3B | 6.6B | 11.93 | 0.35 | ||||
SMALL-CAP | ||||||||
AHCO | 1.3B | 3.2B | -1.91 | 0.41 | ||||
ANIK | 376.6M | 169.3M | -4.9 | 2.23 | ||||
ANGO | 241.9M | 324.0M | -1.26 | 0.75 | ||||
APYX | 56.1M | 50.5M | -2.46 | 1.11 | ||||
AEMD | 1.0M | 3.7M | -0.09 | 0.28 |
Milestone Scientific Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | -0.5% | 2,248,845 | 2,260,596 | 2,059,284 | 2,909,966 | 2,597,598 | 2,240,937 | 2,215,699 | 1,648,368 | 2,700,902 | 2,846,033 | 2,108,233 | 2,425,738 | 2,924,707 | 2,212,066 | 1,246,110 | 167,674 | 1,811,386 | 2,300,921 | 1,899,821 | 2,257,851 | 1,915,909 |
Gross Profit | 11.0% | 1,676,103 | 1,510,075 | 1,503,434 | 1,890,059 | 1,889,463 | 1,085,005 | 1,452,735 | 680,648 | 1,682,426 | 1,780,016 | 1,360,236 | 1,369,354 | 1,802,294 | 1,404,864 | 836,489 | 112,048 | 1,284,136 | 1,539,328 | 1,376,149 | 1,505,668 | 1,297,215 |
Operating Expenses | -10.0% | 3,141,171 | 3,489,617 | 3,010,139 | 4,167,609 | 3,232,139 | 3,099,622 | 3,466,230 | 3,565,527 | 3,596,909 | 3,320,658 | 3,341,157 | 4,241,926 | 2,786,667 | 2,599,758 | 2,313,217 | 3,284,938 | 2,892,742 | 2,665,574 | 2,322,883 | 2,613,499 | 2,115,396 |
S&GA Expenses | -8.0% | 3,035,276 | 3,300,597 | 2,823,765 | 3,937,281 | 3,074,572 | 2,832,996 | 3,283,378 | 3,282,322 | 3,115,629 | 3,008,767 | 2,968,625 | 4,011,672 | 2,749,299 | 2,507,909 | 2,275,274 | 3,155,630 | 2,748,043 | 2,585,466 | 2,314,943 | 2,517,970 | 2,109,050 |
R&D Expenses | -46.7% | 94,211 | 176,906 | 170,478 | 213,647 | 140,347 | 252,992 | 166,191 | 266,560 | 464,466 | 290,167 | 356,179 | 215,420 | 16,444 | 70,762 | 21,438 | 108,170 | 107,480 | 80,108 | 7,940 | 95,529 | 6,346 |
EBITDA Margin | -6.0% | -0.73 | -0.69 | -0.70 | -0.74 | -0.92 | -0.98 | -0.88 | -0.89 | -0.79 | -0.69 | -0.70 | -0.71 | -1.04 | -1.36 | - | - | - | - | - | - | - |
Interest Expenses | -114.7% | -3,351 | 22,859 | 30,600 | 48,722 | 23,345 | 27,788 | 28,012 | 3,550 | -4,742 | -4,756 | -4,608 | -4,461 | -2,535 | -9,353 | -569 | -4,062 | -4,097 | 6,479 | -2,449 | -2,375 | 1,019 |
Income Taxes | - | - | - | - | - | - | - | - | - | - | - | - | 83.00 | 250 | -10,717 | 24,717 | 1,250 | 250 | -1,751 | 1,250 | 14,163 | 4,465 |
Earnings Before Taxes | 26.4% | -1,440,529 | -1,956,683 | -1,476,105 | -2,228,828 | -1,319,331 | -1,986,829 | -1,985,483 | -2,881,329 | -1,919,225 | -1,545,398 | -1,985,529 | -2,600,853 | -986,908 | -1,204,247 | -1,477,297 | -3,176,952 | -1,612,703 | -2,917,861 | -2,848,667 | -1,097,744 | -779,166 |
EBT Margin | -5.5% | -0.75 | -0.71 | -0.71 | -0.75 | -0.94 | -1.00 | -0.89 | -0.90 | -0.80 | -0.69 | -0.70 | -0.71 | -1.05 | -1.37 | - | - | - | - | - | - | - |
Net Income | 25.2% | -1,440,529 | -1,926,739 | -1,466,294 | -2,228,828 | -1,319,331 | -1,953,949 | -1,971,803 | -2,881,329 | -1,919,225 | -1,107,116 | -2,043,207 | -2,696,793 | -985,857 | -1,067,367 | -1,490,989 | -3,178,202 | -1,612,953 | -2,852,155 | -2,836,976 | -1,053,243 | -793,195 |
Net Income Margin | -5.5% | -0.75 | -0.71 | -0.71 | -0.75 | -0.93 | -0.99 | -0.84 | -0.85 | -0.77 | -0.66 | -0.70 | -0.71 | -1.03 | -1.35 | - | - | - | - | - | - | - |
Free Cashflow | 3.7% | -1,200,000 | -1,245,799 | -1,054,396 | -1,024,730 | -2,004,780 | -1,062,340 | -1,141,295 | -2,293,557 | -1,507,508 | -400,342 | -1,565,126 | -1,109,655 | -973,730 | -638,768 | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -0.2% | 11,351 | 11,372 | 10,584 | 11,151 | 12,273 | 13,702 | 15,278 | 13,702 | 19,065 | 19,810 | 20,077 | 21,060 | 22,641 | 19,571 | 19,946 | 20,964 | 6,375 | 6,556 | 6,243 | 6,788 | 7,962 |
Current Assets | 0.2% | 10,812 | 10,794 | 9,973 | 10,500 | 11,581 | 12,971 | 14,515 | 15,714 | 18,228 | 18,934 | 19,159 | 20,105 | 21,659 | 18,555 | 18,892 | 19,881 | 5,261 | 6,077 | 5,756 | 6,296 | 7,314 |
Cash Equivalents | 34.5% | 4,005 | 2,978 | 2,171 | 3,701 | 2,278 | 8,715 | 9,812 | 10,959 | 13,255 | 14,764 | 14,491 | 16,000 | 16,951 | 14,224 | 14,449 | 16,610 | 766 | 1,516 | 1,711 | 2,338 | 2,740 |
Inventory | 8.4% | 2,860 | 2,638 | 2,483 | 2,193 | 2,038 | 1,792 | 1,552 | 1,505 | 1,792 | 1,542 | 1,677 | 1,479 | 2,021 | 2,420 | 2,230 | 1,852 | 1,723 | 1,621 | 1,617 | 1,270 | 1,861 |
Net PPE | -20.0% | 8.00 | 10.00 | 9.00 | 12.00 | 15.00 | 18.00 | 17.00 | 17.00 | 20.00 | 24.00 | 27.00 | 31.00 | 27.00 | 31.00 | 31.00 | 31.00 | 30.00 | 45.00 | 55.00 | 66.00 | 78.00 |
Liabilities | 15.8% | 3,890 | 3,359 | 3,591 | 3,450 | 3,021 | 3,696 | 4,098 | 3,837 | 4,299 | 3,594 | 4,049 | 3,491 | 3,604 | 3,464 | 4,101 | 3,995 | 5,887 | 4,928 | 7,647 | 5,951 | 5,235 |
Current Liabilities | 18.2% | 3,637 | 3,077 | 3,279 | 3,109 | 2,653 | 3,300 | 3,675 | 3,389 | 3,827 | 3,097 | 3,529 | 2,949 | 3,039 | 2,878 | 3,494 | 3,368 | 5,240 | 4,928 | 7,647 | 5,951 | 5,219 |
Shareholder's Equity | -6.9% | 7,460 | 8,013 | 7,246 | 7,702 | 9,252 | 10,226 | 11,181 | 12,676 | 14,766 | 16,215 | 16,028 | 17,568 | 19,037 | 16,107 | 15,845 | 17,009 | 488 | 1,629 | - | 837 | 2,727 |
Retained Earnings | -1.2% | -124,780 | -123,300 | -121,400 | -119,934 | -117,700 | -116,410 | -114,400 | -112,464 | -109,606 | -107,704 | -106,582 | -104,539 | -101,858 | -100,885 | -99,806 | -98,315 | -95,124 | -93,524 | -90,660 | -87,823 | -86,782 |
Additional Paid-In Capital | 0.7% | 133,075 | 132,188 | 129,488 | 128,721 | 128,043 | 127,478 | 126,666 | 126,176 | 125,385 | 124,916 | 123,590 | 123,076 | 121,848 | 117,935 | 116,577 | 116,200 | 96,554 | 96,082 | 90,166 | 89,560 | 90,399 |
Shares Outstanding | 1.0% | 76,602 | 75,849 | 70,860 | 70,074 | 69,306 | 69,273 | 70,481 | 70,357 | 69,013 | 68,120 | 69,574 | 69,221 | 66,578 | 64,138 | - | - | - | - | - | - | - |
Minority Interest | - | - | - | -253 | -243 | -230 | -219 | -206 | -192 | -170 | -152 | -135 | -123 | -107 | -94.43 | -78.39 | -67.36 | -80.01 | -67.27 | -46.74 | -33.80 | -21.84 |
Float | - | - | - | - | 40,047 | - | - | - | 43,102 | - | - | - | 107,317 | - | - | - | 85,818 | - | - | - | 15,369 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | 3.7% | -1,200 | -1,245 | -1,053 | -1,023 | -2,003 | -1,057 | -1,141 | -2,293 | -1,507 | -404 | -1,558 | -1,102 | -967 | -638 | -2,234 | -3,139 | -972 | -503 | -653 | -402 | -220 |
Share Based Compensation | -11.4% | 314 | 354 | 320 | 404 | 389 | 401 | 400 | 392 | 305 | 292 | 192 | 194 | 114 | 474 | 18.00 | 28.00 | 31.00 | 37.00 | 45.00 | 45.00 | 57.00 |
Cashflow From Investing | 489.7% | 2,004 | -514 | -475 | 2,449 | -4,431 | -4.70 | -3.91 | 85* | - | 4.00 | -6.41 | -7.16 | -5.92 | - | -5.94 | -8.36 | -7.14 | - | -1.81 | - | -8.10 |
Cashflow From Financing | -90.6% | 241 | 2,567 | -2.16 | -2.16 | -2.16 | -2.06 | -2.25 | -2.17 | -2.06 | 674 | 79.00 | 136 | 3,701 | 414 | 79.00 | 18,992 | 229 | 309 | 29.00 | 1* | 2,225 |
Consolidated Statements of Operations (Unaudited) - USD ($) | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Product sales, net | $ 2,248,845 | $ 2,597,598 |
Cost of products sold | 572,742 | 708,135 |
Gross profit | 1,676,103 | 1,889,463 |
Selling, general and administrative expenses | 3,035,276 | 3,074,572 |
Research and development expenses | 94,211 | 140,347 |
Depreciation and amortization expense | 11,684 | 17,220 |
Total operating expenses | 3,141,171 | 3,232,139 |
Loss from operations | (1,465,068) | (1,342,676) |
Interest income (expense) | (3,351) | 23,345 |
Unrealized Gain Treasury investment | 27,890 | 0 |
Loss before provision for income taxes | (1,440,529) | (1,319,331) |
Provision for income taxes | 0 | 0 |
Net loss | (1,440,529) | (1,319,331) |
Net loss attributable to noncontrolling interests | 0 | (11,665) |
Net loss attributable to Milestone Scientific Inc. | $ (1,440,529) | $ (1,307,666) |
Net loss per share applicable to common stockholders— | ||
Basic and Diluted (in dollars per share) | $ (0.02) | $ (0.02) |
Weighted average shares outstanding and to be issued— | ||
Basic and Diluted (in shares) | 79,738,551 | 72,104,234 |
Consolidated Balance Sheets (Unaudited) - USD ($) | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 4,005,477 | $ 2,977,713 |
Marketable securities | 1,000,000 | 2,976,573 |
Accounts receivable, net of allowance for credit losses of $10,000, respectively | 661,838 | 312,664 |
Prepaid expenses and other current assets | 863,589 | 517,785 |
Inventories | 2,860,029 | 2,638,186 |
Advances on contracts | 1,421,120 | 1,371,548 |
Total current assets | 10,812,053 | 10,794,469 |
Furniture, fixtures and equipment, net | 8,023 | 10,024 |
Intangibles, net | 168,956 | 178,636 |
Right of use assets finance lease | 6,835 | 8,998 |
Right of use assets operating lease | 330,769 | 355,235 |
Other assets | 24,150 | 24,150 |
Total assets | 11,350,786 | 11,371,512 |
Current liabilities: | ||
Accrued expenses and other payables | 1,241,403 | 1,511,717 |
Accrued expenses, related party | 170,720 | 137,189 |
Accrued Liabilities noncontrolling interest | 214,000 | 214,000 |
Current portion of finance lease liabilities | 8,219 | 10,264 |
Current portion of operating lease liabilities | 107,355 | 103,427 |
Total current liabilities | 3,636,603 | 3,076,713 |
Non-current portion of finance lease liabilities | 0 | 434 |
Non-current portion of operating lease liabilities | 253,774 | 281,853 |
Total liabilities | 3,890,377 | 3,359,000 |
Commitments | ||
Stockholders’ equity | ||
Common stock, par value $0.001; authorized 100,000,000 shares; 76,632,279 shares issued and 76,598,946 shares outstanding as of March 31, 2024 shares; 75,881,840 shares issued and 75,848,507 shares outstanding as of December 31, 2023; | 76,632 | 75,881 |
Additional paid in capital | 133,075,331 | 132,187,656 |
Accumulated deficit | (124,780,038) | (123,339,509) |
Treasury stock, at cost, 33,333 shares | (911,516) | (911,516) |
Total Milestone Scientific, Inc. stockholders' equity | 7,460,409 | 8,012,512 |
Total liabilities and stockholders’ equity | 11,350,786 | 11,371,512 |
Nonrelated Party [Member] | ||
Current liabilities: | ||
Accounts payable | 1,105,589 | 689,604 |
Related Party [Member] | ||
Current liabilities: | ||
Accounts payable | $ 789,317 | $ 410,512 |